Indication

Functional Bowel Disorders

1 clinical trial

1 product

1 drug

Clinical trial

A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial Evaluating Two Dose Regimens of Rifaximin (550 mg Daily or 550 mg Twice Daily) for Chemoprophylaxis Against Travelers' Diarrhea (TD) Among Active Duty Deployed U.S. and British Military Personnel

Status: Completed, Estimated PCD: 2019-07-01

Product

Drug